Service
FDA-approved breakthrough treatment when traditional antidepressants haven’t worked. Experience rapid relief with esketamine nasal spray at Revitalist’s clinics in Knoxville, Johnson City, Tennessee.
When years of antidepressants and therapy sessions haven’t delivered the relief you’re searching for, Spravato® therapy offers a scientifically-proven pathway to healing. Unlike any previous approach to depression treatment, this groundbreaking therapy works through an entirely different brain mechanism, providing hope where traditional methods have fallen short.
At Revitalist, we’re proud to be REMS-certified providers of Spravato® therapy, offering this life-changing treatment to patients across Tennessee and Florida. Our mission extends beyond conventional care, we’re dedicated to pioneering innovative approaches that create genuine breakthroughs in mental health treatment.
Our proven Spravato® therapy has helped patients overcome:
Treatment-resistant depression after multiple medication failures
Major depressive disorder with active suicidal ideation
Severe depression episodes that won't respond to conventional treatment
Long-standing depression that's controlled every aspect of daily life
Depression combined with anxiety that requires rapid intervention
How Spravato® Works Differently:
FDA-Approved: The only nasal spray specifically approved for treatment-resistant depression
Rapid Action: Most patients notice improvements within hours or days, not weeks
Insurance Coverage: Often covered by insurance for qualifying patients
Unique Mechanism: Targets NMDA receptors in the glutamate system
Neuroplasticity Enhancement: Promotes formation of new, healthier brain connections
Research demonstrates that Spravato® blocks NMDA receptors, triggering a cascade of neurobiological changes that essentially “reset” dysfunctional brain circuits associated with depression. This innovative approach allows your brain to develop new pathways around the damaged areas that have kept you trapped in depression.
Speed of Relief
Spravato® Therapy
Hours to days
Traditional Antidepressants
Success Rate
Spravato® Therapy
Traditional Antidepressants
10-30% for treatment-resistant cases
Spravato® Therapy
Often covered for approved indications
Traditional Antidepressants
Generally covered but limited effectiveness
Mechanism of Action
Spravato® Therapy
Glutamate/NMDA system
Traditional Antidepressants
Serotonin/dopamine systems
Spravato® Therapy
Traditional Antidepressants
Daily self-administered pills
Spravato® Therapy
Traditional Antidepressants
Often persistent and ongoing
“I had given up hope after trying 12 different antidepressants over 8 years. Nothing worked, and I was planning my suicide. Spravato literally saved my life. I felt a shift in my mood within hours of my first treatment, and now six months later, I’m experiencing joy I never thought was possible.”
– Amanda K., Johnson City Patient
“Treatment-resistant depression stole 15 years of my life. I couldn’t function, couldn’t work, couldn’t be the mother my children needed. Spravato®
gave me back everything I thought I’d lost forever. The convenience of the nasal spray and insurance coverage made it accessible when nothing else was.”
– Rebecca S., Tampa Patient
– David M., Knoxville Patient
Don’t wait another day for improvement that traditional treatments may never provide. Our expert medical team is ready to evaluate whether Spravato® therapy could be the breakthrough you’ve been seeking.
Our specialized Spravato® protocols provide rapid relief for FDA-approved mental health conditions:
When two or more antidepressants haven’t provided adequate relief
Rapid intervention for patients with active suicidal thoughts
Spravato’s®
remarkable effectiveness stems from its revolutionary mechanism of action that differs fundamentally from all previous depression treatments.
While conventional antidepressants slowly modify serotonin levels over months, Spravato works rapidly through glutamate—the brain’s primary excitatory neurotransmitter responsible for 90% of brain communication. This system directly controls learning, memory formation, and emotional processing.
By blocking NMDA receptors, Spravato® triggers a powerful cascade of neurobiological changes including:
Clinical research published in JAMA Psychiatry demonstrates that Spravato® activates mTOR signaling pathways, which are crucial for protein synthesis and synaptic plasticity. This glutamate modulation creates rapid structural changes in neural networks within hours, compared to the weeks or months required for serotonin-based treatments to show meaningful effects.
Treatment-resistant depression creates overactive, rigid neural circuits that trap patients in cycles of negative thinking, hopelessness, and emotional numbness. Traditional antidepressants work slowly within these same dysfunctional pathways, often providing limited relief.
Spravato® works differently by creating new neural pathways that bypass these damaged circuits entirely. Think of it like building new highways around a traffic-jammed interstate—Spravato opens fresh routes for healthy brain communication while the old, problematic pathways naturally weaken from disuse.
Landmark research from Mount Sinai Medical Center shows that Spravato®
can restore synaptic connections that have been severely damaged by chronic stress and depression. The TRANSFORM-1 study published in the International Journal of Neuropsychopharmacology demonstrated rapid improvement in treatment-resistant depression within 24 hours of Spravato administration, with effects sustained for weeks. This neuroplastic reset explains why patients often experience not just symptom relief, but genuine shifts in perspective, improved emotional regulation, and renewed ability to engage with life.
Emerging research reveals that Spravato’s® antidepressant effects may also result from its ability to rapidly reduce neuroinflammation—a key factor in treatment-resistant depression that traditional medications often fail to address effectively.
Chronic brain inflammation disrupts neurotransmitter function and contributes to the persistent, treatment-resistant nature of severe depression. Spravato® appears to interrupt these inflammatory cascades while simultaneously promoting neuroplasticity, providing comprehensive healing through multiple biological mechanisms.
Research from leading academic medical centers indicates that patients with higher baseline inflammation markers often respond particularly well to Spravato® therapy. The ASPIRE-I study demonstrated that Spravato® can rapidly reduce suicidal ideation in patients with major depressive disorder, suggesting that its anti-inflammatory effects work alongside glutamate modulation to create profound therapeutic changes. This dual mechanism helps explain why Spravato® succeeds where traditional antidepressants have failed, offering hope for patients who previously had no effective treatment options.
Your healing journey begins with a comprehensive evaluation by our REMS-certified medical team. We’ll thoroughly review your medical history, current symptoms, previous treatment attempts, and assess whether Spravato® therapy is appropriate for your specific condition.
During this consultation, we’ll verify your insurance benefits, explain the prior authorization process if needed, and provide detailed information about what to expect during each phase of treatment. This consultation helps ensure you feel completely informed and confident before beginning therapy.
Pre-Treatment Preparation: Before your session, we’ll provide specific instructions about avoiding food for two hours and liquids for 30 minutes prior to administration.
The Session: You’ll self-administer the Spravato® nasal spray under direct supervision of our medical team in one of our comfortable, private treatment rooms designed specifically for healing and recovery.
Environment: Each location features:
Monitoring: Our medical staff continuously monitors your vital signs and response throughout the required 2-hour observation period, ensuring your safety and comfort at all times.
To maximize your Spravato® therapy benefits, we offer psychotherapy to integrate your treatment experience into lasting improvements. This support helps you understand any insights gained during treatment and develop strategies for maintaining progress between sessions.
After completing your initial treatment series, we’ll work with you to develop a personalized maintenance schedule, adjusting frequency based on your response and needs to sustain long-term improvement.
We are fully certified under the FDA's Risk Evaluation and Mitigation Strategy (REMS) program, meeting the highest standards for safe Spravato® administration. This certification ensures you receive treatment that meets all federal safety requirements.
Our board-certified physicians have extensive experience with esketamine therapy and advanced training in treating complex, treatment-resistant depression. We stay current with the latest research and protocols to ensure optimal outcomes.
Unlike many innovative treatments, Spravato is often covered by insurance for qualifying patients. Our experienced team navigates prior authorization processes and works directly with insurance providers to maximize your benefits and minimize out-of-pocket costs.
Each Revitalist location features modern facilities designed specifically for Spravato® therapy. Our private treatment rooms provide a calming environment with luxury amenities to ensure comfort during your 2-hour monitoring period.
With hundreds of successful Spravato® treatments across our three locations, Revitalist has established itself as a trusted leader in esketamine therapy. Our patients consistently report significant improvements in depression symptoms and quality of life.
We offer comprehensive mental health treatment including: Spravato® Treatment - FDA-approved esketamine nasal spray IV Ketamine Therapy - Intravenous ketamine for broader applications Neuropeptide Therapy - Advanced peptide treatments for brain health Vitamin Infusions - Nutritional support for optimal mental wellness
These effects typically resolve within 1-2 hours after treatment ends. Our medical team provides continuous monitoring throughout your session and observation period to ensure your comfort and safety.
Spravato® therapy may not be appropriate for individuals with:
During your consultation, our medical team will thoroughly review your health history and current medications to determine if Spravato® therapy is safe and appropriate for you.
Many patients report noticeable improvements within hours or days of their first treatment. Unlike traditional antidepressants that can take 4-8 weeks to show effects, Spravato’s rapid action through the glutamate system often provides relief during the first treatment session.
The FDA-approved protocol includes twice-weekly treatments for the first month (induction phase), weekly treatments for the second month (maintenance phase), and then weekly or bi-weekly treatments based on your response (continuation phase). Your specific protocol will be customized based on your individual needs and response to treatment.
Yes, many major insurance plans cover Spravato for FDA-approved indications like treatment-resistant depression. Coverage typically requires prior authorization and documentation of previous treatment failures. Our team will verify your specific benefits and guide you through the approval process.
No, you cannot drive or operate machinery until the next day after receiving Spravato. You must arrange transportation home after each session. This is a mandatory safety requirement due to the medication’s effects on cognition and coordination.
Your first session will begin with final preparations and a review of the self-administration process. You’ll use the simple nasal spray device under our medical team’s supervision, then relax in our comfortable treatment room during the required 2-hour monitoring period. Our staff will ensure your comfort and safety throughout the entire process.
Spravato is FDA-approved specifically for treatment-resistant depression and is often covered by insurance, while ketamine infusions are used off-label for various conditions and typically aren’t covered. Spravato is self-administered as a convenient nasal spray, while ketamine requires IV infusion. Both contain the same active compound but in different formulations.
Yes, Spravato was specifically developed and FDA-approved for treatment-resistant depression. Clinical trials demonstrated significant effectiveness in patients who had failed to respond to multiple previous antidepressants. The unique glutamate mechanism offers hope when serotonin-based treatments haven’t provided relief.
No, Spravato is designed to be used alongside an oral antidepressant as combination therapy. You should continue your current medications unless specifically directed otherwise by your healthcare provider. Our medical team will review your medications and coordinate with your psychiatrist as needed.
Long-term studies show that continued Spravato treatment can provide sustained improvement in depression symptoms with manageable side effects. The SUSTAIN studies demonstrated that patients who responded to initial treatment could maintain their improvement with ongoing therapy. Regular monitoring ensures safe, effective long-term use.
Take the first step toward healing:
Free Assessment
Personalized treatment plan designed for your specific condition
Rapid relief often within hours of your first treatment
Insurance coverage verification and prior authorization support
Compassionate care from experienced mental health professionals
Revitalist is committed to providing safe, effective Spravato®
therapy that transforms lives. With REMS-certified locations in Knoxville and Johnson City, Tennessee, we’re here to help you find the relief you deserve when traditional treatments have failed.
